These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9762413)

  • 1. RGD-containing trypsin with both platelet aggregation inhibitory activity and proteolytic activity.
    Nie X; Tang JG
    Biochem Mol Biol Int; 1998 Sep; 45(6):1149-54. PubMed ID: 9762413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities.
    Chen H; Mo W; Su H; Zhang Y; Song H
    BMC Mol Biol; 2007 Oct; 8():88. PubMed ID: 17919340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins.
    Reiss S; Sieber M; Oberle V; Wentzel A; Spangenberg P; Claus R; Kolmar H; Lösche W
    Platelets; 2006 May; 17(3):153-7. PubMed ID: 16702041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via the integrin receptors.
    Williams JA
    Pathol Biol (Paris); 1992 Oct; 40(8):813-21. PubMed ID: 1484742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Site-directed mutagenesis of the gene of Echistatin Leu14-Lys15-Glu16].
    Li H; Li X; Hu M
    Yi Chuan Xue Bao; 1996; 23(2):163-8. PubMed ID: 8695184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the single substitution of arginine within the RGD tripeptide motif of a modified neurotoxin dendroaspin on its activity of platelet aggregation and cell adhesion.
    Lu X; Davies J; Lu D; Xia M; Wattam B; Shang D; Sun Y; Scully M; Kakkar V
    Cell Commun Adhes; 2006; 13(3):171-83. PubMed ID: 16798616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular design, expression and characterization of novel bifunctional mutants of fibrolase with combined platelet aggregation-inhibition and fibrinolytic activity.
    Fang HM; Zhao L; Lu P; Chen SJ; Bao ZX; Qin YF; Zhu ZY; Zhao JM; Mai J; Zhang ST
    Protein J; 2011 Apr; 30(4):247-52. PubMed ID: 21479991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin binding characteristics of the disintegrin-like domain of ADAM-15.
    Lu D; Chung KF; Xia M; Lu X; Scully M; Kakkar V
    Thromb Haemost; 2006 Nov; 96(5):642-51. PubMed ID: 17080222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-dependent vasorelaxant and anti-aggregatory effect and mechanism of action of some antifibrinogen RGD (Arg-Gly-Asp-containing) peptides.
    Torday LL; Pataricza J; Balogh GE; Zarándi M; Penke B; Papp JG
    J Pharm Pharmacol; 1998 Jun; 50(6):667-71. PubMed ID: 9680079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity.
    Ozeki E; Matsuda T
    ASAIO Trans; 1990; 36(3):M562-4. PubMed ID: 2252751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet aggregation of a mutant proinsulin molecule engineered by introduction of a native Arg-Gly-Asp sequence.
    Yang ZH; Jing J; Tang JG
    Appl Biochem Biotechnol; 2001 Jan; 90(1):1-10. PubMed ID: 11257802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function.
    van Wyk V; Leblond L; Winocour PD; Devine DV; Gyongyossy-Issa MI
    Thromb Res; 2000 Aug; 99(4):343-52. PubMed ID: 10963785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and activity analysis of RGD-mSAK (K130T, K135R)].
    Ning BA; Ma R; Zheng YL; Gao ZX; Shen B; Jiang YQ
    Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):456-60. PubMed ID: 16108374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
    Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
    Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
    Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.